We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
+0.73%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$655M
AUM Growth
+$3.66M
Cap. Flow
+$9.57M
Cap. Flow %
1.46%
Top 10 Hldgs %
32.39%
Holding
187
New
13
Increased
39
Reduced
92
Closed
8

Top Buys

Rank Stock Value
1
SOLV icon
Solventum
SOLV
+$4.39M
2
CRM icon
Salesforce
CRM
+$3.93M
3
WTRG icon
Essential Utilities
WTRG
+$3.55M
4
TDC icon
Teradata
TDC
+$3.44M
5
HAL icon
Halliburton
HAL
+$3.15M

Sector Composition

Rank Sector Weight
1 Technology 33.86%
2 Healthcare 16.16%
3 Industrials 15.33%
4 Utilities 10.02%
5 Energy 6.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LNN icon
26
Lindsay Corp
LNN
$1.13B
$7.07M 1.08%
57,559
-1,216
-2% -$142K
HON icon
27
Honeywell
HON
$77B
$6.89M 1.05%
34,237
-478
-1% -$90.9K
GNRC icon
28
Generac Holdings
GNRC
$11.6B
$6.71M 1.02%
50,775
-650
-1% -$89.8K
GVA icon
29
Granite Construction
GVA
$5.29B
$6.6M 1.01%
106,460
-800
-0.7% -$47.4K
FISV
30
Fiserv Inc
FISV
$28.8B
$6.42M 0.98%
43,051
-400
-0.9% -$60.5K
ITRI icon
31
Itron
ITRI
$4.36B
$6.12M 0.93%
61,799
-659
-1% -$66.3K
TMP icon
32
Tompkins Financial
TMP
$1.43B
$6.05M 0.92%
123,727
+21,862
+21% +$1.01M
JAZZ icon
33
Jazz Pharmaceuticals
JAZZ
$15.9B
$6.03M 0.92%
56,494
+26,344
+87% +$2.9M
COHR icon
34
Coherent
COHR
$51.4B
$5.94M 0.91%
82,000
-450
-0.5% -$27.1K
POR icon
35
Portland General Electric
POR
$5.8B
$5.8M 0.88%
134,143
-4,509
-3% -$194K
NJR icon
36
New Jersey Resources
NJR
$5.84B
$5.55M 0.85%
129,828
-1,585
-1% -$68.4K
LOW icon
37
Lowe's Companies
LOW
$117B
$4.95M 0.75%
22,441
+466
+2% +$106K
SYY icon
38
Sysco
SYY
$40.8B
$4.88M 0.74%
68,292
-1,143
-2% -$85.4K
NXST icon
39
Nexstar Media Group
NXST
$5.82B
$4.74M 0.72%
28,543
-400
-1% -$65K
AGX icon
40
Argan
AGX
$8B
$4.68M 0.71%
64,000
-92,129
-59% -$6.04M
EQIX icon
41
Equinix
EQIX
$101B
$4.59M 0.7%
6,070
+25
+0.4% +$19K
HRI icon
42
Herc Holdings
HRI
$5.02B
$4.57M 0.7%
34,321
-150
-0.4% -$22.2K
MCO icon
43
Moody's
MCO
$82.8B
$4.42M 0.67%
10,507
-350
-3% -$139K
GEHC icon
44
GE HealthCare
GEHC
$30.7B
$4.42M 0.67%
56,692
-381
-0.7% -$31.1K
LITE icon
45
Lumentum
LITE
$55.5B
$4.39M 0.67%
86,238
+12,265
+17% +$556K
LGTY
46
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$4.36M 0.67%
477,995
-112,825
-19% -$1.15M
GRC icon
47
Gorman-Rupp
GRC
$2.14B
$4.3M 0.66%
117,201
-903
-0.8% -$31.9K
KNF icon
48
Knife River
KNF
$4.15B
$4.28M 0.65%
61,072
-802
-1% -$59.9K
AZTA icon
49
Azenta
AZTA
$1.3B
$4.24M 0.65%
80,493
-475
-0.6% -$25.4K
VOO icon
50
Vanguard S&P 500 ETF
VOO
$979B
$4.15M 0.63%
8,298
-254
-3% -$122K

Similar funds

John G. Ullman & Associates's Q2 2024 Portfolio in Review

As of Q2 2024, John G. Ullman & Associates held 187 positions worth $655M, up 0.56% from $652M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

John G. Ullman & Associates's Q2 2024 filing shows 13 new, 39 increased, 92 reduced and 8 closed positions. Its largest new stake was Solventum: 72,250 shares worth $3.82M. The largest sale was Argan, an estimated $6.04M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Industrials.

  • John G. Ullman & Associates's largest Q2 2024 buy was Solventum: 72,250 shares worth $3.82M.
  • John G. Ullman & Associates added most to Halliburton in Q2 2024, an estimated $3.15M increase.
  • John G. Ullman & Associates's biggest Q2 2024 reduction was Argan, cutting an estimated $6.04M.
  • John G. Ullman & Associates fully exited Hewlett Packard in Q2 2024, selling an estimated $505K.
  • John G. Ullman & Associates's ten largest holdings make up 32% of its $655M portfolio in Q2 2024.
  • John G. Ullman & Associates opened 13 new positions and closed 8 in Q2 2024.
  • John G. Ullman & Associates's portfolio value rose 0.56% quarter-over-quarter to $655M.

Based on John G. Ullman & Associates's 13F filing for Q2 2024, filed 8 Aug 2024.